Calidad de vida, complicaciones asociadas y satisfacción con el uso de pesarios para tratamiento conservador del prolapso de órganos pélvicos / Quality of life, associated complications and satisfaction with pessary use for conservative treatment of pelvic organ prolapse

Antecedentes: El tratamiento conservador para prolapso de órganos pélvicos (POP) está indicado cuando la paciente rechaza la cirugía o cuando existe contraindicación quirúrgica por condiciones médicas adversas. Objetivo: Evaluar la calidad de vida, complicaciones y percepción subjetiva de mejora en mujeres con POP en tratamiento con pesarios en la Unidad de Uroginecología del Hospital Militar, Santiago, Chile, entre 2009 y 2018. Método: Estudio retrospectivo que evaluó 60 mujeres con POP en tratamiento con pesarios. Las variables sociodemográficas y datos clínicos fueron recopilados al inicio del tratamiento y durante los controles de abril del 2018 a marzo del 2019. Además, se aplicaron dos cuestionarios validados: Percepción Subjetiva de Mejora y Prolapse Quality of Life (PQoL). Resultados: El pesario más utilizado fue el ring (75%), el promedio de edad 78,7 años (± 8,2), las complicaciones más reportadas fueron: vulvovaginitis, erosión, infección del tracto urinario y brida. Un 80% de las mujeres reportó excelente mejora en su condición de salud, las demás refirieron sentirse entre bastante y algo mejor. Las mujeres con erosión y vulvovaginitis presentaron mayor tiempo de uso del pesario versus las que no tuvieron estas complicaciones (p < 0,05). En general, la calidad de vida asociada al POP y uso de pesario fue buena. Las mujeres que tuvieron síntomas de incontinencia urinaria (IU) presentaron mayor compromiso en calidad de vida en los dominios «impacto del POP» y «limitaciones sociales» (p < 0,05). Conclusión: El tratamiento conservador con pesarios mostró buenos resultados, en la percepción subjetiva de mejora y en la calidad de vida, y bajo porcentaje de complicaciones.(AU)

Background: Conservative treatment for pelvic organ prolapse (POP) is indicated when the patient refuses surgery, or when there is surgical contraindication due to adverse medical conditions. Objective: To evaluate the quality of life, complications, and perception of health improvement in women with POP on treatment with pessaries in the Urogynaecology Unit of the Military Hospital, Santiago Chile between 2009 and 2018. Method: Retrospective study that evaluated 60 women with POP on treatment with pessaries. Sociodemographic variables and clinical data were collected at the beginning of the treatment and during follow-up from April 2018 to March 2019. Two validated questionnaires were also completed: Subjective Perception of Improvement and Prolapse Quality of Life (PQoL). Results: The ring was the most commonly used pessary (75%). The mean age of the patients was 78.7 years (± 8.2). The most reported complications were: vulvovaginitis, erosion, urinary tract infection, and flange. Around 80% of the patients reported an excellent improvement in their health condition, and 20% reported feeling better. Women with erosion and vulvovaginitis had a longer time of pessary use compared to women who did not have these complications (p < 0.05). In general, Quality of Life associated with prolapse and pessary use was good. Women with urinary incontinence showed a worse quality of life in domains «impact of prolapse» and «social limitations» (p < 0.05). Conclusion: Conservative treatment with pessaries showed good results in subjective perception of improvement, good quality of life, and low percentage of complications.(AU)

Melanoma Awareness Among Medical Students.

Melanoma is the most aggressive skin cancer. Since diagnosis is visual, it is critical to evaluate if students acquire enough knowledge for early detection during medical school. To assess the melanoma knowledge of first-year (freshman) and sixth-year (senior) medical students, in a Brazilian Institution. It was a transversal and quantitative study. A questionnaire with sociodemographic data, knowledge about melanoma, and the habit of skin self-exam was filled out by medical students. A total of 128 first-year and 122 seniors students were included. All the sixth-year students knew melanoma as a skin cancer compared with 46.09% of the first-year students. Melanoma clinical characteristics were known by 30.51% of the freshman and 97.54% of seniors. However, they did not know the most usual site of melanoma occurrence (79.66% of first-year students and 24.59% of senior). About the skin self-exam, only 50% of first-year students and 53.28% of senior had the habit of doing it sometimes. Medical school was effective in providing knowledge about melanoma and its features. However, this was not reflected in an increase in the number of students that did the skin self-exam, which indicates the need for new approaches in teaching.

Access to innovative medicines for metastatic melanoma worldwide: Melanoma World Society and European Association of Dermato-oncology survey in 34 countries.

According to data from recent studies from Europe, a large percentage of patients have restricted access to innovative medicines for metastatic melanoma. Melanoma World Society and European Association of Dermato-oncology conducted a Web-based survey on access to first-line recommended treatments for metastatic melanoma by current guidelines (National Comprehensive Center Network, European Society for Medical Oncology [ESMO] and European Organization for Research and Treatment of Cancer/European Association of Dermato-oncology/European dermatology Forum) among melanoma experts from 27 European countries, USA, China, Australia, Argentina, Brazil, Chile and Mexico from September 1st, 2017 to July 1st, 2018. Data on licencing and reimbursement of medicines and the number of patient treated were correlated with the data on health expenditure per capita (HEPC), Mackenbach score of health policy performance, health technology assessment (HTA), ASCO and ESMO Magnitude of clinical benefit scale (ESMO MCBS) scores of clinical benefit and market price of medicines. Regression analysis for evaluation of correlation between the parameters was carried out using SPSS software. The estimated number of patients without access in surveyed countries was 13768. The recommended BRAFi + MEKi combination and anti-PD1 immunotherapy were fully reimbursed/covered in 19 of 34 (55.8%) and 17 of 34 (50%) countries, and combination anti-CTLA4+anti-PD1 in was fully covered in 6 of 34 (17.6%) countries. Median delay in reimbursement was 991 days, and it was in significant correlation with ESMO MCBS (p = 0.02), median market price (p = 0.001), HEPC and Mackenbach scores (p < 0.01). Price negotiations or managed entry agreements (MEAs) with national authorities were necessary for reimbursement. In conclusion, great discrepancy exists in metastatic melanoma treatment globally. Access to innovative medicines is in correlation with economic parameters as well as with healthcare system performance parameters. Patient-oriented drug development, market access and reimbursement pathways must be urgently found.

Sentinel node biopsy using blue dye and technetium99 in advanced gastric cancer: anatomical drainage and clinical application.

Lymph node metastases are an independent prognosis factor in gastric carcinoma (GC) patients. Radical lymphadenectomy can improve survival but it can also increase surgical morbidity. As a principle, sentinel node (SN) navigation surgery can avoid unnecessary lymphadenectomy without compromising prognosis. In this pilot study, 24 patients with untreated GC were initially screened for SN navigation surgery, of which 12 were eligible. Five patients had T2 tumors, 5 had T3 tumors and 2 had T1 tumors. In 33% of cases, tumor diameter was greater than 5.0 cm. Three hundred and eighty-seven lymph nodes were excised with a median of 32.3 per patient. The SN navigation surgery was feasible in all patients, with a median of 4.5 SNs per patient. The detection success rate was 100%. All the SNs were located in N1 and N2 nodal level. In 70.9% of cases, the SNs were located at lymphatic chains 6 and 7. The SN sensitivity for nodal staging was 91.6%, with 8.3% of false negative. In 4 patients who were initially staged as N0, the SNs were submitted to multisection analyses and immunohistochemistry, confirming the N0 stage, without micrometastases. In one case initially staged as negative for nodal metastases based on SN analyses, metastases in lymph nodes other than SN were found, resulting in a 20% skip metastases incidence. This surgery is a reproducible procedure with 100% detection rate of SN. Tumor size, GC location and obesity were factors that imposed some limitations regarding SN identification. Results from nodal multisection histology and immunohistochemistry analysis did not change initial nodal staging.

Sentinel node biopsy using blue dye and technetium99 in advanced gastric cancer: anatomical drainage and clinical application

Lymph node metastases are an independent prognosis factor in gastric carcinoma (GC) patients. Radical lymphadenectomy can improve survival but it can also increase surgical morbidity. As a principle, sentinel node (SN) navigation surgery can avoid unnecessary lymphadenectomy without compromising prognosis. In this pilot study, 24 patients with untreated GC were initially screened for SN navigation surgery, of which 12 were eligible. Five patients had T2 tumors, 5 had T3 tumors and 2 had T1 tumors. In 33% of cases, tumor diameter was greater than 5.0 cm. Three hundred and eighty-seven lymph nodes were excised with a median of 32.3 per patient. The SN navigation surgery was feasible in all patients, with a median of 4.5 SNs per patient. The detection success rate was 100%. All the SNs were located in N1 and N2 nodal level. In 70.9% of cases, the SNs were located at lymphatic chains 6 and 7. The SN sensitivity for nodal staging was 91.6%, with 8.3% of false negative. In 4 patients who were initially staged as N0, the SNs were submitted to multisection analyses and immunohistochemistry, confirming the N0 stage, without micrometastases. In one case initially staged as negative for nodal metastases based on SN analyses, metastases in lymph nodes other than SN were found, resulting in a 20% skip metastases incidence. This surgery is a reproducible procedure with 100% detection rate of SN. Tumor size, GC location and obesity were factors that imposed some limitations regarding SN identification. Results from nodal multisection histology and immunohistochemistry analysis did not change initial nodal staging.

A new mouse model for evaluating the immunotherapy of human colorectal cancer.

A new murine model of human colorectal cancer was generated by crossing human carcinoembryonic antigen (CEA) transgenic mice (H-2K(b)) with adenomatous polyposis coli (Apc1638N) knockout mice (H-2K(b)). The resulting hybrid mice developed gastrointestinal polyps in 6-8 months that progressed to invasive carcinomas with a similar pattern of dysplasia and CEA expression as observed in human colorectal cancer. These animals exhibited incomplete or partial tolerance to CEA as evidenced by delayed growth of CEA-expressing tumors and the inability to inhibit CEA-specific CTL responses. These results have important implications for understanding the role of CEA-specific immunity in human colon cancer patients and suggest that vaccine strategies targeting CEA may be feasible. This model provides a powerful system for evaluating antigen-specific tumor immunity against spontaneous tumors arising in an orthotopic location and permits evaluation of therapeutic vaccine strategies for human colorectal cancer.

[Rectal lymphoma: report of a case and considerations on its etiology, diagnosis, and therapy]. / Linfoma retal: apresentação de um caso e considerações sobre sua etiologia, diagnóstico e tratamento.

Primary rectal lymphomas are rare tumors representing less than 2% of the neoplasms of the colon. Common symptoms are the same that occur in carcinoma of the rectum. Patients treated surgically have a better prognosis. Chemotherapy and radiation therapy should be considered in some cases. A case of primary rectal lymphoma is presented and the literature reviewed.

Acute fatty liver of pregnancy: a clinical study of 12 episodes in 11 patients.

Twelve episodes of acute fatty liver of pregnancy (AFLP) were diagnosed in 11 patients during the past 18 years in a general hospital in Santiago, Chile, with a prevalence of 1 per 15,900 deliveries. Acute fatty liver of pregnancy started between the 31st and 38th weeks of pregnancy, with malaise, vomiting, jaundice, and lethargy as the main clinical manifestations. Polydipsia (in nine episodes) and skin pruritus (in seven episodes) were unusual clinical findings. In two patients, pruritus started two and four weeks before AFLP, suggesting that an intrahepatic cholestasis of pregnancy preceded AFLP in those patients. Considering the current prevalence of both diseases in Chile, their association should be considered fortuitous. In another patient, two consecutive pregnancies were affected by AFLP, raising to three the number of reported patients with recurrent AFLP. In 11 episodes, liver biopsies supported the diagnosis of AFLP by showing small and midsized vacuolar cytoplasmic transformation as the most prominent histopathological feature. Positive intracellular fat staining was found in the four samples analysed. Studies by electron microscopy showed megamitochondria with paracrystalline inclusions in four samples. All the mothers survived, but fetal mortality was 58.3%. Several extrahepatic complications delayed maternal recovery for up to four weeks after delivery. This study confirms an improvement in maternal prognosis in AFLP, discusses the possibility of an epidemiological association with intrahepatic cholestasis of pregnancy, and increases the number of patients reported with recurrent AFLP.

[Echographic-histological correlation in ovarian neoplasms]. / Correlación ecográfico-histológica de tumores ováricos.

One hundred women who had surgical intervention indicated for pelvic masses, were studied prospectively, all of them were investigated and treated in the obstetrical and gynecology Department of the Hospital del Salvador between January 1988 to January 1989. Pelvic tumors were classified following the scheme at the University of Tokyo's Obstetrician and Gynecology Department, which was designated to correlate the echographic image with the tumors histology and especially to distinguish preoperatively the benign or malign nature of the mass. The early diagnosis of ovarian cancer in the general population was not the objective. The classification divides the tumors in 6 groups with two o three subgroups for each one of them the probability of the tumors being benign was high for those in the group one to four (the predictive value of non malignancy was 98.4%) and the possibility of malignancy was high especially in the group 6 (the predictive value for malignancy was 63.6%).